首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Selective inhibition of carbonic anhydrase IX and XII by coumarin and psoralen derivatives
Authors:Rita Meleddu  Serenella Deplano  Elias Maccioni  Francesco Ortuso  Filippo Cottiglia  Daniela Secci  Alessia Onali  Erica Sanna  Andrea Angeli  Rossella Angius  Stefano Alcaro  Claudiu T Supuran  Simona Distinto
Institution:aDepartment of Life and Environmental Sciences, University of Cagliari, Monserrato, Italy;bDipartimento di Scienze della Salute, Università Magna Graecia di Catanzaro, Catanzaro, Italy;cDipartimento NEUROFARBA, Sezione di Scienze Farmaceutiche, Università degli Studi di Firenze, Sesto Fiorentino, Italy;dLaboratorio NMR e Tecnologie Bioanalitiche, Sardegna Ricerche, Pula, Italy
Abstract:A small library of coumarin and their psoralen analogues EMAC10157a-b-d-g and EMAC10160a-b-d-g has been designed and synthesised to investigate the effect of structural modifications on their inhibition ability and selectivity profile towards carbonic anhydrase isoforms I, II, IX, and XII. None of the new compounds exhibited activity towards hCA I and II isozymes. Conversely, both coumarin and psoralen derivatives were active against tumour associated isoforms IX and XII in the low micromolar or nanomolar range of concentration. These data further corroborate our previous findings on analogous derivatives, confirming that both coumarins and psoralens are interesting scaffolds for the design of isozyme selective hCA inhibitors.
Keywords:hCAi  tumour  coumarin  psoralen  docking
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号